INDUSTRY ACADEMIC COOPERATION FOUNDATION; HALLYM UNIVERSITY
发明人:
SHIN, YOUNG JOOKR,신영주
申请号：
KR1020130097880
公开号：
KR1020150020867A
申请日:
2013.08.19
申请国别(地区):
KR
年份:
2015
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing or treating corneal damage, which can prevent corneal opacity caused by corneal damage. When treating rapamycin of the present invention, it can be confirmed that generation of corneal opacity is inhibited. Rapamycin which is an active ingredient of the present invention can be added in the effective dose of 0.00001-1000 mg/ml for an oral drug and 0.0001-200 mg/ml for an eyewash drug.COPYRIGHT KIPO 2015본 발명은 각막 손상으로 발생되는 각막 혼탁을 방지할 수 있는 각막 손상 예방 또는 치료용 약제학적 조성물에 관한 것으로, 본 발명의 라파마이신을 처리할 경우, 각막 혼탁의 생성이 억제됨을 확인할 수 있었다.
